Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis

Journal of Medicinal Chemistry

Volumn 49, Issue 17, 2006, Pages 5072-5079

  Carotenuto, Alfonso ^a   D'Ursi, Anna Maria ^b   Mulinacci, Barbara ^c   Paolini, Ilaria ^c   Lolli, Francesco ^c   Papini, Anna Maria ^c   Novellino, Ettore ^a   Rovero, Paolo ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; GLYCOPEPTIDE; SYNTHETIC PEPTIDE;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; AUTOIMMUNE DISEASE; BETA SHEET; BLOOD SAMPLING; DEMYELINATING DISEASE; DRUG CONFORMATION; DRUG EFFECT; GLYCOSYLATION; HUMAN; MULTIPLE SCLEROSIS; PEPTIDE SYNTHESIS; PROTEIN PROCESSING; STRUCTURE ACTIVITY RELATION;

ANTIGEN-ANTIBODY REACTIONS; AUTOANTIBODIES; BIOLOGICAL MARKERS; DRUG DESIGN; GLYCOPEPTIDES; MOLECULAR PROBES; MULTIPLE SCLEROSIS; PEPTIDE LIBRARY; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33747478288     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060117j     Document Type: Article

References (42)

1. Baker, M. In Biomarker We Trust? Nature Biotechnol. 2005, 23, 297-304.
2. Bischoff, R.; Luider, T. M. Methodological Advances in the Discovery of Protein and Peptide Disease Biomarkers. J. Chromatogr. 2003, 803, 27-40.
3. Leslie, D.; Lipsky, P.; Notkins, A. L. Autoantibodies as Predictors of Disease. J. Clin. Invest. 2001, 108, 1417-1422.
4. Doyle, H. A.; Mamula, M. J. Posttranslational Protein Modifications in Antigen Recognition and Autoimmunity. Trends Immunol. 2001, 22, 443-449.
5. Lolli, F.; Mulinacci, B.; Carotenuto, A.; Bonetti, B.; Sabatino, G.; Mazzanti, B.; D'Ursi, A. M.; Novellino, E.; Pazzagli, M.; Lovato, L.; Alcaro, M. C.; Peroni, E.; Pozo-Carrero, M. C.; Nuti, F.; Battistini, L.; Borsellino, G.; Chelli, M.; Rovero, P.; Papini, A. M. An N-Glucosylated Peptide Detecting Disease-Specific Autoantibodies, Biomarkers of Multiple Sclerosis. Proc. Natl. Acad. Sci. 2005, 102, 10273-10278.
6. Lolli, F.; Mazzanti, B.; Pazzagli, M.; Peroni, E.; Alcaro, M. C.; Sabatino, G.; Lanzillo, R.; Brescia Morra, V.; Santoro, L.; Gasperini, C.; Galgani, S.; D'Elios, M. M.; Zipoli, V.; Sotgiu, S.; Pugliatti, M.; Rovero, P.; Chelli, M.; Papini, A. M. The Glycopeptide CSF114-(Glc) Detects Serum Antibodies in Multiple Sclerosis. J. Neuroimmunol. 2005, 167, 131-137.
7. Thompson, A. J. Clinical Review of Multiple Sclerosis. Clin. Immunother. 1996, 5, 1-11.
8. de Seze, J.; Dubucquoi, S.; Lefranc, D.; Virecoulon, F.; Nuez, I.; Dutoit, V.; Vermersch, P.; Prin, L. IgG Reactivity against Citrullinated Myelin Basic Protein in Multiple Sclerosis. J. Neuroimmunol. 2001, 117, 149-155.
9. Kim, J. K.; Mastronardi, F. G.; Wood, D. D.; Lubman, D. M.; Zand, R.; Moscarello, M. A. Multiple Sclerosis. An Important Role for Posttranslational Modifications of Myelin Basic Protein in Pathogenesis Mol. Cell. Proteomics 2003, 2, 453-462.
10. Papini, A. M. Simple Test for Multiple Sclerosis. Nat. Med. 2005, 11, 13.
11. Mazzucco, S.; Matà, S.; Vergelli, M.; Fioresi, R.; Nardi, E.; Mazzanti, B.; Chelli, M.; Lolli, F.; Ginanneschi, M.; Pinto, F.; Massacesi, L.; Papini, A. M. A Synthetic Glycopeptide of Human Myelin Oligodendrocyte Glycoprotein to Detect Antibody Response in Multiple Sclerosis and other Neurological Diseases. Bioorg. Med. Chem. Lett. 1999, 9, 167-172.
12. Carotenuto, A.; D'Ursi, A. M.; Nardi, E.; Papini, A. M.; Rovero, P. Conformational Analysis of a Glycosylated Human Myelin Oligodendrocyte Glycoprotein Peptide Epitope Able to Detect Antibody Response in Multiple Sclerosis. J. Med. Chem. 2001, 44, 2378-2381.
13. Ramirez-Alvarado, M.; Blanco, F. J. Niemann, H.; Serrano, L. Role of β-Turn Residues in β-Hairpin Formation and Stability in Designed Peptides. J. Mol. Biol. 1997, 273, 898-912.
14. Pastor, M. T.; de la Paz, M. L.; Lacroix, E.; Serrano, L.; Perez-Paya, E. Combinatorial Approaches: A New Tool to Search for Highly Structured β-Hairpin Peptides. Proc. Natl. Acad. Sci. 2002, 99, 614-619.
15. Rajan, R.; Awasthi, K. S.; Bhattacharjya, S.; Balaram, P. Teflon-coated Peptides: Hexafluoroacetone Trihydrate as a Structure Stabilizer for Peptides. Biopolymers 1997, 42, 125-128.
16. Wüthrich, K. NMR of Proteins and nucleic acids; John Wiley & Sons: New York, 1986.
17. a) Piantini, U.; Sorensen, O. W.; Ernst, R. R. Multiple Quantum Filters for Elucidating NMR Coupling Network. J. Am. Chem. Soc. 1982, 104, 4, 6800-6801.
18. 1H Spin-Spin Coupling Constants in Proteins. Biochem. Biophys. Res. Commun. 1983, 113, 967-974.
19. Bax, A.; Davis, D. G. Mlev-17-Based Two-Dimensional Homonuclear Magnetization Transfer Spectroscopy. J. Magn. Reson. 1985, 65, 355-360.
20. Jenner, J.; Meyer, B. H.; Bachman, P.; Ernst, R. R. Investigation of Exchange Processes by Two-Dimensional NMR Spectroscopy. J. Chem. Phys. 1979, 71, 4546-4553.
21. Bartels, C.; Xia, T.; Billeter, M.; Güntert, P.; Wüthrich, K. The Program XEASY for Computer-Supported NMR Spectral Analysis of Biological Macromolecules. J. Biomol. NMR 1995, 6, 1-10.
22. a) Wishart, D. S.; Sykes, B. D.; Richards, F. M. The Chemical Shift Index: A Fast Method for the Assignment of Protein Secondary Structure through NMR Spectroscopy. Biochemistry 1992, 31, 1647-1651.
23. (b) Andersen, N. H.; Liu, Z.; Prickett, K. S. Efforts toward deriving the CD spectrum of a 3(10) helix in aqueous medium. FEBS Lett. 1996, 399, 47-52.
24. Guntert P.; Mumenthaler C.; Wüthrich, K. Torsion Angle Dynamics for NMR Structure Calculation with the New Program DYANA. J. Mol. Biol. 1997, 273, 283-298.
25. Kihlberg, J.; Ahman, J. Glycosylated Peptide Hormones: Pharmacological Properties and Conformational Studies of Analogues of [1-Desamino, 8-D-Arginine]Vasopressine J. Med. Chem. 1995, 38, 161-169.
26. Hruby, V. J. Conformational and Topographical Considerations in the Design of Biologically Active Peptides. Biopolymers 1993, 33, 1073-1082.
27. Garcia-Merino, A.; Persson, M. A.; Ernerudh, J.; Diaz-Gil, J. J.; Olsson, T. Serum and Cerebrospinal Fluid Antibodies against Myelin Basic Protein and their IgG Subclass Distribution in Multiple Sclerosis. J. Neurol. Neurosurg. Psychiatry 1986, 49, 1066-1070.
28. Mathiesen, T.; von Holst, H.; Fredrikson, S.; Wirsen, G.; Hederstedt, B.; Norrby, E.; Sundqvist, V. A.; Wahren, B.; Total, Anti-Viral, and Anti-Myelin IgG Subclass Reactivity in Inflammatory Diseases of the Central Nervous System. J. Neurol. 1989, 256, 238-242.
29. Egg, R.; Reindl, M.; Deisenhammer, F.; Linington, C.; Berger, T. Anti-MOG and Anti-MBP Antibody Subclasses in Multiple Sclerosis. Mult. Scler. 2001, 7, 285-289.
30. Schrijver, I. A.; van Meurs, M.; Melief, M. J.; Wim Ang, C.; Buljevac, D.; Ravid, R.; Hazenberg, M. P.; Laman, J. D. Bacterial Peptidoglycan and Immune Reactivity in the Central Nervous System in Multiple Sclerosis. Brain 2001, 124, 1544-1554.
31. Matyszak, M. K. Inflammation in the CNS: Balance between Immunological Privilege and Immune Responses. Prog. Neurobiol. 1998, 56, 19-35.
32. Persson, M. A.; Laurenzi, M. A.; Vranjesevic, D. Extended Repertoire of Specific Antibodies in CSF of Patients with Subacute Sclerosing Panencephalitis Compared to those with Multiple Sclerosis: Anti-Bacterial Antibodies are also Increased. J. Neuroimmunol. 1989, 22, 135-142.
33. Hughes, L. E.; Smith, P. A.; Bonell, S.; Natt, R. S.; Wilson, C.; Rashid, T.; Amor, S.; Thompson, E. J.; Croker, J.; Ebringer, A. Crossreactivity between Related Sequences Found in Acinetobacter sp., Pseudomonas aeruginosa, Myelin Basic Protein and Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis. J. Neuroimmunol. 2003, 144, 105-115.
34. Yuki, N.; Susuki, K.; Koga, M.; Nishimoto, Y.; Odaka, M.; Hirata, K.; Taguchi, K.; Miyatake, T.; Furukawa, K.; Kobata, T.; Yamada, M. Carbohydrate Mimicry between Human Ganglioside GM1 and Campylobacter jejuni Lipooligosaccharide Causes Guillain-Barre Syndrome. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 11404-11409.
35. a) Kappos, L.; Achtnichts, L.; Dahlke, F.; Kuhle, J.; Naegeli, Y.; Sandbink, R.; Lindberg, R. L. P. Genomics and Proteomics: Role in the Management of Multiple Sclerosis. J. Neurol. 2005, 252, 21-27.
36. (b) Ibrahim, S. M.; Gold, R. Genomics, Proteomics, Metabolomics: What is in a word for Multiple Sclerosis. Curr. Opin. Neurol. 2005, 18, 231-235.
37. Gill, S. C.; von Hippel, P. H. Calculation of Protein Extinction Coefficients from Amino Acid Sequence Data. Anal. Biochem. 1989, 182, 319-26.
38. Adler, A. J.; Greenfield, N. J.; Fasman, G. D. Circular dichroism and Optical Rotatory Dispersion of Proteins and Polypeptides. Methods Enzymol. 1973, 27, 675-735.
39. States, D. J.; Haberkorn, R. A.; Ruben, D. J. A Two-Dimensional Nuclear Overhauser Experiment with Pure Absorption Phase Four Quadrants. J. Magn. Reson. 1982, 48, 286-292.
40. Koradi, R., Billeter, M., Wüthrich, K. MOLMOL: A Program for Display and Analysis of Macromolecular Structures. J. Mol. Graphics 1996, 14, 51-55.
41. Maple, J.; Dinur, U.; Hagler, A. T. Derivation of Force Fields for Molecular Mechanics and Dynamics from Ab Initio Energy Surface. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 5350-5354.
42. Hutchinson, E. G.; Thornton, J. M. PROMOTIF- A Program to Identify and Analyze Structural Motifs in Proteins. Protein Sci. 1996, 5, 212-220.